Header image

Concurrent 7B - Hypercholesterolaemia and Lp(a)

Tracks
Track 2
Saturday, November 21, 2026
10:45 - 11:30
Hall A

Details

Presented by our Gold Partner - Sonic Healthcare Familial hypercholesterolaemia is to identify patients and families who should be identified and tested. FH is a significant cause of early morbidity and mortality with patients who have it have a significant increase in heart disease and early death due to acute myocardial infarctions. Early identification and treatment significant change patients outcomes as well as identifying family members who will also benefit from early treatment. Initial testing requires a specialist but cascade testing for family members can be ordered by any doctor. Lipoprotein a (Lp(a)) is a test used to assess a patient’s cardiovascular risk category. This is currently a non-modifiable risk factor. Recent changes to US and European guidelines have recommended that patients should have this test once throughout their life to see who may need early intervention treatment.


Speaker

Agenda Item Image
Dr Travis Brown
General Pathologist
Sonic Clinpath Pathology

Hypercholesterolaemia and Lp(a)

Dr Travis Brown is a general pathologist in Clinpath Pathology. He works predominantly in chemical pathology and microbiology. He is chair of the Pathology Informatics committee for the RCPA. He is also co-host of This Medical Life podcast which is a podcast for doctors.
Agenda Item Image
Dr Tracey Purnell
Chair
RACGP Dermatology Specific Interest Group

Chairperson

10:45 - 11:30

Dr Tracey Purnell MBBS, M.Med (Skin Cancer), FRACGP, FACAM. Tracey is a skin cancer and aesthetic medicine specific interest GP based in Wagga Wagga NSW. She is the Chair of the RACGP Dermatology specific interest group and a senior lecturer in skin cancer medicine at the University of Queensland.
loading